Cantitate/Preț
Produs
Total produse
Vezi coșul
Acute Myeloid Leukemia in Children: Standard of Care and Future Perspectives de Daisuke Tomizawa

Acute Myeloid Leukemia in Children: Standard of Care and Future Perspectives: Pediatric Oncology

Editat de Daisuke Tomizawa, Edward Anders Kolb, Dirk Reinhardt
en Limba Engleză Hardback – 27 sep 2024
This book provides up-to-date information on key topics and issues in Pediatric Acute Myeloid Leukemia (AML), including the epidemiology, biology, diagnosis and treatment of particular forms of the disease, supportive care, and survivorship. The entire spectrum of clinical management on pediatric AML is covered with the aim of equipping readers with the latest knowledge relevant to clinical practice and research, based on enormous efforts made by cooperative clinical trial groups and consortia worldwide. Each chapter is written by internationally renowned authorities who have been selected for their expertise in the subjects discussed. This book will serve pediatric hematologists/oncologists, fellows, and residents both as a comprehensive source of information and as a quick reference. The book will also be of interest to pediatricians and general practitioners.
Citește tot Restrânge

Din seria Pediatric Oncology

  • 5% Supportive Care in Pediatric Oncology: A Practical Evidence-Based Approach
    Preț: 104817 lei
  • 5% Pediatric Radiation Oncology
    Preț: 119671 lei
  • 5% Bone Marrow Failure
    Preț: 91742 lei
  • 5% Pediatric Cancer Therapeutics Development
    Preț: 64281 lei
  • 5% Neuroblastoma: Discoveries and Challenges
    Preț: 116795 lei
  • 5% Renal Tumors of Childhood: Biology and Therapy
    Preț: 73055 lei
  • 5% Pediatric Germ Cell Tumors: Biology Treatment Survivorship
    Preț: 37238 lei
  • 5% Integrative Pediatric Oncology
    Preț: 72470 lei
  • 5% Pediatric Bone and Soft Tissue Sarcomas
    Preț: 73346 lei
  • 5% Pediatric Lymphomas
    Preț: 69274 lei
  • 5% Retinoblastoma
    Preț: 128230 lei
  • 5% Childhood Leukemia: A Practical Handbook
    Preț: 97547 lei
  • 5% Pediatric Liver Tumors
    Preț: 96348 lei
  • 5% Cancer in Adolescents and Young Adults
    Preț: 179645 lei
  • 5% Hematopoietic Cell Transplantation in Children with Cancer
    Preț: 130584 lei
  • 5% Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach
    Preț: 73606 lei
  • 5% Malignant Pediatric Bone Tumors - Treatment & Management
    Preț: 72998 lei
  • 5% Pediatric CNS Tumors
    Preț: 85268 lei
  • 5% Cancer in Adolescents and Young Adults
    Preț: 200723 lei
  • 5% Palliative Care in Pediatric Oncology
    Preț: 86615 lei
  • 5% Imaging in Pediatric Oncology
    Preț: 82814 lei
  • 5% Pediatric Oncology Nursing: Advanced Clinical Handbook
    Preț: 134078 lei
  • 5% Pediatric Oncology Nursing: Defining Care Through Science
    Preț: 61398 lei
  • 5% Sarcomas of Bone and Soft Tissues in Children and Adolescents
    Preț: 65518 lei
  • 5% Rare Tumors in Children and Adolescents
    Preț: 103378 lei

Preț: 106010 lei

Preț vechi: 111590 lei
-5% Nou

Puncte Express: 1590
Preț estimativ în valută:
20290€ • 21103$ • 17003£

Carte disponibilă

Livrare economică 20 februarie-06 martie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783031633652
ISBN-10: 3031633652
Pagini: 462
Ilustrații: Approx. 460 p. 70 illus., 25 illus. in color.
Dimensiuni: 178 x 254 mm
Ediția:2024
Editura: Springer Nature Switzerland
Colecția Springer
Seria Pediatric Oncology

Locul publicării:Cham, Switzerland

Cuprins

 Part-1: Epidemiology and Biology of Pediatric AML. Overview and Epidemiology of Pediatric AML.-  Chromosomal and Genomic Alterations in Pediatric AML.-  Germline Predisposition of Pediatric AML. Part-2: Diagnosis of pediatric AML. Diagnosis and Classifications of Pediatric AML.-  Measurable Residual Disease Assessment in Pediatric AML. Part-3: Advances in Treatment of Pediatric AML. De Novo AML.-  Extramedullary AML (CNS disease. non-CNS extramedullary disease. and myeloid sarcoma).-  Acute Promyelocytic Leukemia.-  Myeloid Proliferations Associated with Down Syndrome (ML-DS. TAM).-  Myeloproliferative Disorders in Non-Down Syndrome Patients.-  AML in Specific Age Groups (Infants. Adolescents and Young Adults).-  Myeloid Neoplasms Post Cytotoxic Therapy in Children.-  Advanced MDS in Children.-  Relapsed/Refractory AML in Children and Evolution of Novel Therapies.-  Stem Cell Transplantation/Cellular and Immunotherapies.-  Pediatric AML in Resource-Limited Countries. Part-4: Supportive Issues in Pediatric AML. Infection Management in Pediatric AML.-  Cardiotoxicity in Pediatric AML.-  Late effects in Pediatric AML Survivors.

Notă biografică

Dr. Daisuke Tomizawa is a pediatric hematologist/oncologist and Head of the Division of Leukemia and Lymphoma at the Children's Cancer Center, National Center for Child Health and Development in Tokyo, Japan. He served as Vice Chair of the Japan Children's Cancer Group (JCCG) acute myeloid leukemia (AML) disease committee from 2010-2019 and Chair from 2019-2023, which is responsible for the design and conduct of clinical trials and linked translational research studies that enroll approximately 80% of Japanese children and adolescents with this disease. He is also involved in various international research projects in collaboration with North American, Western European, and Asian investigators in this field.
Dr. Edward Anders Kolb is a pediatric hematologist/oncologist, and most recently served as Chief of the Division of Hematology and Oncology of Nemours Children’s Health, Wilmington, Delaware, and Professor of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Kolb also served as Chair of the Children’s Oncology Group (COG) Myeloid Disease Committee from 2013-2023, which is the largest pediatric AML research consortium in the world. He is a strong advocate for international collaboration and leads the development of several international clinical trials. Since 2023, Dr. Kolb was appointed as President and Chief Executive Officer, The Leukemia & Lymphoma Society (LLS) in its mission to cure blood cancers and improve the quality of life for patients and their families.
Prof. Dr. Dirk Reinhardt is a pediatric hematologist/oncologist and Head of Pediatrics III, Pediatric Hematology, Oncology and Stem Cell Therapy at the University Children's Hospital Essen, Germany. He is chairman of the AML-BFM study group, which conducts clinical trials as well as basic and translational research on pediatric AML. As Managing Director of the German Society for Pediatric Oncology and Hematology (GPOH gGmbH) and Director of the EuPAL Foundation, he promotes international projects in drug and therapy development for the treatment of cancer and leukemia in children.
 
 

Textul de pe ultima copertă

This book provides up-to-date information on key topics and issues in Pediatric Acute Myeloid Leukemia (AML), including the epidemiology, biology, diagnosis and treatment of particular forms of the disease, supportive care, and survivorship. The entire spectrum of clinical management on pediatric AML is covered with the aim of equipping readers with the latest knowledge relevant to clinical practice and research, based on enormous efforts made by cooperative clinical trial groups and consortia worldwide. Each chapter is written by internationally renowned authorities who have been selected for their expertise in the subjects discussed. This book will serve pediatric hematologists/oncologists, fellows, and residents both as a comprehensive source of information and as a quick reference. The book will also be of interest to pediatricians and general practitioners.

Caracteristici

Covers key aspects of pediatric AML including basic science diagnosis and treatment Presents up-to-date information on treatment for pediatric AML based on recently completed clinical trials Provides readers with novel information on the biology of pediatric AML